UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-39765
Frazier Lifesciences Acquisition Corporation
(Exact name of registrant as specified in its charter)
Two Union Square
601 Union St., Suite 3200
Seattle, Washington 98101
(206) 621-7200
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Units, each consisting of one Class A Ordinary Share, and one-third of one Warrant to acquire one Class A Ordinary Share
Class A Ordinary Shares, par value $0.0001 per share
Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | ☒ | |
Rule 12g-4(a)(2) | ☐ | |
Rule 12h-3(b)(1)(i) | ☒ | |
Rule 12h-3(b)(1)(ii) | ☐ | |
Rule 15d-6 | ☐ | |
Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: one (1).
Pursuant to the requirements of the Securities Exchange Act of 1934, Frazier Lifesciences Acquisition Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: December 2, 2022 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION | |||||
| By: | /s/ Louise Kooij | |||||
| Name: | Louise Kooij | |||||
| Title: | Treasurer | |||||
